Skip to main content
SpringerLink
Log in

High Risk Groups and Cost Strategies

  • Chapter
Approaches to Breast Cancer Prevention

Part of the book series: Developments in Oncology ((DION,volume 62))

Abstract

Primary prevention of breast cancer is now a scientific and clinical possibility, but the formal demonstration of the effectiveness of a chemopreventive agent requires a carefully conducted prospective, randomized placebo-controlled clinical trial. If resources were unlimited, such a trial would be designed to enroll a very large number of postmenopausal women at risk and follow them for many years to observe different rates of breast cancer incidence between the treatment groups. Practical economic considerations necessitate a trial design that yields an informative result with the smallest possible number of subjects in a relatively short period of time.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kelsey, J.L. (1979). A review of the epidemiology of human breast cancer. Epidemiol. Rev., 1, 74–109.

    PubMed  CAS  Google Scholar 

  2. Kelsey, J.L., Berkowitz, G.S. (1988). Breast cancer epidemiology. Cancer Res., 48, 5615–5623.

    PubMed  CAS  Google Scholar 

  3. Petrakis, N.L., Ernster, V.L., King, M.C. (1982). Breast. In Schottenfeld, D., Fraumeni, J.F., Jr (eds.) Cancer Epidemiology and Prevention, W.B. Saunders, Philadelphia, 855–870.

    Google Scholar 

  4. US Bureau of the Census. (1989). Statistical Abstract of the United States, 1989 (109th edition), Washington, DC, 13–17.

    Google Scholar 

  5. Surveillance, Epidemiology, and End Results: Incidence and Mortality Data, 1973–77, (1981). NIH Publication No. 81–2330, DHHS, PHS, NCI, Bethesda.

    Google Scholar 

  6. Lynch, J.T., Albano, W.A., Heieck, J.J. et al. (1984). Genetics, biomarkers, and control of breast cancer: a review. Cancer Genet. Cytogenet., 13, 43–92.

    Article  PubMed  CAS  Google Scholar 

  7. Williams, W.R., Osborne, M.P. (1987). Familial aspects of breast cancer: an overview, In Harris, J.R., Henderson, I.C., Hellman, S., Kinne, D.W. (eds.), Breast Diseases, J.B. Lippincott Philadelphia, 109–120.

    Google Scholar 

  8. Adami, H.-O., Hansen, J., Jung, B., Rinsten, A. (1981). Characteristics of familial breast cancer in Sweden: absence of relation to age and unilateral versus bilateral disease. Cancer, 48, 1688–1695.

    Article  PubMed  CAS  Google Scholar 

  9. Brinton, L.A., Hoover, R., Fraumeni, J.F. (1982). Interaction of familial and hormonal risk factors for breast cancer. J. Natl. Cancer Inst., 69, 817–822.

    PubMed  CAS  Google Scholar 

  10. Dubin, N., Pasternack, B.S., Strax, P. (1984). Epidemiology of breast cancer in a screened population. Cancer Detect. Prevent., 7, 87–102.

    PubMed  CAS  Google Scholar 

  11. Sattin, R.W., Rubin, G.L., Webster, L.A., et al. (1985). Family history and the risk of breast cancer. J. Am. Med. Assoc., 253, 1908–1913.

    Article  CAS  Google Scholar 

  12. Hislop, T.G., Coldman, A.J., Elwood, J.M., et al. (1986). Relationship between risk factors for breast cancer and hormonal status. Int. J. Epidemiol., 15, 469–476.

    Article  PubMed  CAS  Google Scholar 

  13. Ernster, V.L. (1989). The epidemiology of benign breast disease. Epidemiol. Rev., 3, 184–202.

    Google Scholar 

  14. McDivitt, R.W., Stewart, F.W., Berg, J.W. (1968). Tumors of the Breast. (Atlas of Tumor Pathology. Second series. Part 2). Armed Forces Institute of Pathology, Washington DC, 29–49.

    Google Scholar 

  15. Azzopardi, J.G. (1979). Problems in Breast Pathology. W.B. Saunders, Philadelphia, 113–149, 192–239.

    Google Scholar 

  16. Dupont, W.D., Page, D.L. (1985). Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med., 312, 146–151.

    Article  PubMed  CAS  Google Scholar 

  17. Hislop, T.G., Elwood, J.M. (1981). Risk factors for benign breast disease: a 30-year cohort study. Can. Med. Assoc., 124, 283–291.

    CAS  Google Scholar 

  18. Ory, H., Cole, P., MacMahon, B., Hoover, R. (1976). Oral contraceptives and reduced risk of benign breast diseases. N. Engl. J. Med., 294, 419–422.

    Article  PubMed  CAS  Google Scholar 

  19. Cole, P., Elwood, J.M., Kaplan, S.D. (1978). Incidence and rates and risk factors of benign breast neoplasms. Am. J. Epidemiol., 108, 112–120.

    PubMed  CAS  Google Scholar 

  20. Vogel, V.G. (1991). High risk populations as targets for breast cancer prevention trials. Prev. Med., (In press).

    Google Scholar 

  21. Brisson, J., Morrison, A.S., Kopans, D.B., et al. (1984). Height and weight, mammographic features of breast tissue and breast cancer risk. Am. J. Epidemiol., 119, 371–381.

    PubMed  CAS  Google Scholar 

  22. Carlile, T., Kopecky, K.J., Thompson, D.J. et al. (1985). Breast cancer prediction and the Wolfe classification of mammograms. J. Am. Med. Assoc., 254, 1050–1053.

    Article  CAS  Google Scholar 

  23. Bergkvist, L., Tabar, L., Bergstrom, R., Adami, H.-O. (1987). Epidemiologic determinants of the mammographic parenchymal pattern. A population-based study within a mammographic screening program. Am. J. Epidemiol., 126, 1075–1081.

    PubMed  CAS  Google Scholar 

  24. Brisson, J., Morrison, A.S., Khalid, N. (1988). Mammographic parenchymal features and breast cancer in the Breast Cancer Detection Demonstration Project. J. Natl. Cancer Inst., 80, 1534–1540.

    Article  PubMed  CAS  Google Scholar 

  25. Saftlas, A.F., Wolfe, J.N., Hoover, R.N. et al. (1989). Mammographic parenchymal pattern as indicators of breast cancer risk.v4m. J. Epidemiol., 129, 518–526.

    CAS  Google Scholar 

  26. Wolfe, J.N. (1976). Breast patterns as an index of risk for developing breast cancer. Am. J. Roentgen., 126, 1130–1139.

    CAS  Google Scholar 

  27. Zapka, J.G., Stoddard, A.M., Costanza, M.E., Greene, H.L. (1989). Breast cancer screening by mammography: utilization and associated factors. Am. J. Publ. Hlth., 79, 1499–1502.

    Article  CAS  Google Scholar 

  28. Love, R.R. (1990). Prospects for antiestrogen chemoprevention of breast cancer. J. Natl. Cancer Inst., 82, 18–21.

    Article  PubMed  CAS  Google Scholar 

  29. Mace, A.E. (1974). Sample-she Determination, Robert E Krieger Huntington, New York, 101–104.

    Google Scholar 

  30. Eddy, D.S. (1989). Screening for breast cancer. Ann. Intern. Med., 111, 389–399.

    PubMed  CAS  Google Scholar 

  31. Meinert, C.L. (1986). Clinical Trials: Design, Conduct, and Analysis, Oxford University Press, New York, 30–39.

    Google Scholar 

  32. Winn, R., Vogel, V., Graves, D., Coody, D. (1989). Determinants of women’s willingness to participate in a breast cancer chemoprevention trial (BCCPT) utilizing tamoxifen. Proc. Am. Soc. Clin. Oncol., 8, 61.

    Google Scholar 

  33. Taplin, S., Anderman, C., Grothaus, L. (1989). Breast cancer risk and participation in mam-mographic screening. Am. J. Publ. Hlth., 79, 1494–1498.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Victor G. Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard R. Love
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oncology Department St Thomas’ Hospital, and to Joint Breast Clinic, Royal Free Hospital, London, UK

    Basil A. Stoll FRCR, FFR (Honorary Consulting Physician) (Honorary Consulting Physician)

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Vogel, V.G., Love, R.R. (1991). High Risk Groups and Cost Strategies. In: Stoll, B.A. (eds) Approaches to Breast Cancer Prevention. Developments in Oncology, vol 62. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-3742-3_14

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-3742-3_14

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-5664-9

  • Online ISBN: 978-94-011-3742-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation